Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

TSXV:RX - Post Discussion

Biosyent Inc > share buyback
View:
Post by lscfa on Apr 13, 2022 12:51pm

share buyback

Filed 2022-04-10 09:12
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$33,096
+3,641 vol
$9.09 each
66,190  
Filed 2022-04-08 07:47
 
Tx date 2022-03-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-20,600 vol
0  
Filed 2022-04-08 07:47
 
Tx date 2022-03-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,240
+400 vol
$8.10 each
226,100  
Filed 2022-04-08 07:45
 
Tx date 2022-03-10
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,650
+200 vol
$8.25 each
20,600  
Filed 2022-04-08 07:45
 
Tx date 2022-03-09
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,912
+600 vol
$8.19 each
20,400  
Filed 2022-04-08 07:44
 
Tx date 2022-03-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,437
+4,200 vol
$8.20 each
19,800  
Filed 2022-04-08 07:43
 
Tx date 2022-03-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$73,710,000
+900 vol
$81,900 each
15,600  
Filed 2022-04-08 07:42
 
Tx date 2022-03-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,920
+600 vol
$8.20 each
14,700  
Filed 2022-04-08 07:42
 
Tx date 2022-03-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,849
+8,400 vol
$8.20 each
14,100  
Filed 2022-04-08 07:41
 
Tx date 2022-03-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,200
+1,000 vol
$8.20 each
5,700
Filed 2022-04-05 08:05
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$23,997
+2,640 vol
$9.09 each
15,605  
Filed 2022-04-04 09:25
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$138,004
+15,182 vol
$9.09 each
966,344  
Filed 2022-04-03 16:40
 
Tx date 2022-03-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+5,721 vol
43,424  
Filed 2022-04-01 14:56
 
Tx date 2022-03-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$53,603
+5,897 vol
$9.09 each
44,864  
Filed 2022-04-01 09:58
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$33,096
+3,641 vol
$9.09 each
46,658  
Filed 2022-04-01 09:50
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$29,842
+3,283 vol
$9.09 each
14,512  
Filed 2022-04-01 09:35
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+4,292 vol
170,284  
Filed 2022-04-01 09:16
 
Tx date 2022-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
$25,997
+2,860 vol
$9.09 each
19,924  
Filed 2022-04-01 07:48
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Elford, Sara
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights

+1,980 vol
12,550  
Filed 2022-04-01 07:10
 
Tx date 2022-03-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights

+1,072 vol
104,635
Filed 2022-04-01 07:00
 
Tx date 2022-03-31
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-9,050
-1,000 vol
$9.05 each
17,064  
Filed 2022-03-31 11:16
 
Tx date 2022-03-29
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-9,050
-1,000 vol
$9.05 each
18,064  
Filed 2022-03-31 10:59
 
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-9,110.88
-999 vol
$9.12 each
7,760  
Filed 2022-03-31 10:56
 
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-8,118.01
-901 vol
$9.01 each
8,759  
Filed 2022-03-31 10:55
 
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-8,920
-1,000 vol
$8.92 each
9,660  
Filed 2022-03-31 10:54
 
Tx date 2022-03-29
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options
$-15,651.59
-1,741 vol
$8.99 each
10,660  
Filed 2022-03-31 10:33
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Atwal, Neelu
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,989
+1,166 vol
$7.71 each
12,965  
Filed 2022-03-29 15:30
 
Tx date 2022-03-24
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-19,910
-2,200 vol
$9.05 each
62,549  
Filed 2022-03-28 17:25
 
Tx date 2022-03-24
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-39,622.59
-5,193 vol
$7.63 each
11,229
Filed 2022-03-25 14:41
 
Tx date 2022-03-22
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-4,475
-500 vol
$8.95 each
19,564  
Filed 2022-03-25 14:39
 
Tx date 2022-03-24
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-4,550
-500 vol
$9.10 each
19,064  
Filed 2022-03-24 13:03
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Goehrum, Rene
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,688
+1,516 vol
$7.71 each
951,162  
Filed 2022-03-23 10:27
 
Tx date 2022-03-21
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,341.60
-607 vol
$8.80 each
16,422  
Filed 2022-03-23 08:29
 
Tx date 2022-03-18
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-68,697.51
-8,247 vol
$8.33 each
17,029  
Filed 2022-03-22 06:21
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$671.44
+88 vol
$7.63 each
103,563  
Filed 2022-03-21 15:35
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,682
+737 vol
$7.71 each
64,749  
Filed 2022-03-21 05:14
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Andrews, Larry
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,060
+270 vol
$7.63 each
10,580  
Filed 2022-03-16 13:08
 
Tx date 2021-12-31
$RX
BioSyent Inc.
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+858 vol
37,703  
Filed 2022-03-15 16:33
 
Tx date 2021-12-31
$RX
BioSyent Inc.
March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$17,270
+2,240 vol
$7.71 each
38,967  
Filed 2022-03-14 21:12
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,181
+672 vol
$7.71 each
25,276  
Filed 2022-03-14 09:40
 
Tx date 2021-12-13
$RX
BioSyent Inc.
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,317
+560 vol
$7.71 each
20,064
Filed 2022-03-14 09:21
 
Tx date 2021-12-31
$RX
BioSyent Inc.
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,364
+1,474 vol
$7.71 each
43,017  
Filed 2022-03-10 08:48
 
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$17,622
+2,200 vol
$8.01 each
225,700  
Filed 2022-03-10 08:47
 
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,305
+4,700 vol
$8.15 each
4,700  
Filed 2022-03-10 08:46
 
Tx date 2022-02-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-6,600 vol
0  
Filed 2022-03-10 08:45
 
Tx date 2022-02-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-64,900 vol
6,600  
Filed 2022-03-10 08:44
 
Tx date 2022-02-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$52,932
+6,600 vol
$8.02 each
71,500  
Filed 2022-03-10 08:44
 
Tx date 2022-02-23
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$114,799
+14,000 vol
$8.20 each
64,900  
Filed 2022-03-10 08:42
 
Tx date 2022-02-22
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$84,530
+10,400 vol
$8.13 each
50,900  
Filed 2022-03-10 08:41
 
Tx date 2022-02-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,434
+3,000 vol
$8.14 each
40,500  
Filed 2022-03-10 08:41
 
Tx date 2022-02-17
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,966
+3,800 vol
$8.15 each
37,500  
Filed 2022-03-10 08:40
 
Tx date 2022-02-16
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,228
+1,400 vol
$8.02 each
33,700  
Filed 2022-03-10 08:39
 
Tx date 2022-02-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,005
+500 vol
$8.01 each
32,300
Filed 2022-03-10 08:38
 
Tx date 2022-02-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,976
+4,700 vol
$8.08 each
31,800  
Filed 2022-03-10 08:38
 
Tx date 2022-02-08
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,179
+1,500 vol
$8.12 each
27,100  
Filed 2022-03-10 08:27
 
Tx date 2022-02-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,079
+3,100 vol
$8.09 each
25,600  
Filed 2022-03-10 08:27
 
Tx date 2022-02-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,250
+2,500 vol
$8.10 each
22,500  
Filed 2022-03-10 08:26
 
Tx date 2022-02-03
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,479
+4,000 vol
$8.12 each
20,000  
Filed 2022-03-10 08:25
 
Tx date 2022-02-02
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,000
+1,000 vol
$8.00 each
16,000  
Filed 2022-03-10 08:24
 
Tx date 2022-02-01
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,600
+1,200 vol
$8.00 each
15,000  
Filed 2022-02-10 08:21
 
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$55,927
+7,000 vol
$7.99 each
223,500  
Filed 2022-02-10 08:20
 
Tx date 2022-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Holder: Canadian Western Trust (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$120,349
+15,000 vol
$8.02 each
216,500  
Filed 2022-02-01 13:13
 
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-32,700 vol
13,800  
Filed 2022-02-01 13:12
 
Tx date 2022-01-31
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$797.00
+100 vol
$7.97 each
46,500  
Filed 2022-02-01 13:12
 
Tx date 2022-01-28
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,454
+1,700 vol
$7.91 each
46,400
Filed 2022-02-01 13:11
 
Tx date 2022-01-27
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,415
+8,800 vol
$8.00 each
44,700  
Filed 2022-02-01 13:10
 
Tx date 2022-01-26
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,400
+2,300 vol
$8.00 each
35,900  
Filed 2022-02-01 13:08
 
Tx date 2022-01-25
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,200
+900 vol
$8.00 each
33,600  
Filed 2022-02-01 13:08
 
Tx date 2022-01-24
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,759
+6,100 vol
$7.99 each
32,700  
Filed 2022-02-01 13:06
 
Tx date 2022-01-20
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$805.00
+100 vol
$8.05 each
26,600  
Filed 2022-02-01 13:05
 
Tx date 2022-01-19
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,385
+4,500 vol
$8.09 each
26,500  
Filed 2022-02-01 13:04
 
Tx date 2022-01-18
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,069
+2,600 vol
$8.10 each
22,000  
Filed 2022-02-01 13:04
 
Tx date 2022-01-14
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,440
+2,400 vol
$8.10 each
19,400  
Filed 2022-02-01 13:03
 
Tx date 2022-01-13
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,900
+1,200 vol
$8.25 each
17,000  
Filed 2022-02-01 13:02
 
Tx date 2022-01-12
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,900
+1,200 vol
$8.25 each
15,800  
Filed 2022-02-01 13:01
 
Tx date 2022-01-11
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,620
+2,500 vol
$8.25 each
14,600  
Filed 2022-02-01 13:00
 
Tx date 2022-01-07
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,060
+3,000 vol
$8.02 each
12,100
Filed 2022-02-01 12:59
 
Tx date 2022-01-06
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,174
+3,000 vol
$8.06 each
9,100  
Filed 2022-02-01 12:59
 
Tx date 2022-01-05
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,490
+2,900 vol
$8.10 each
6,100  
Filed 2022-02-01 12:58
 
Tx date 2022-01-04
$RX
BioSyent Inc.
BioSyent Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,764
+2,900 vol
$8.19 each
3,200
Comment by overnout on Apr 13, 2022 1:10pm
Nice that they still see value in buying shares back north of $8
Comment by prophetoffact on Apr 13, 2022 2:03pm
This post has been removed in accordance with Community Policy
Comment by lscfa on Apr 13, 2022 3:15pm
Why would execs exercise options with $9.12 strike price and years to expiry?   
Comment by overnout on Apr 13, 2022 4:15pm
Dividend?
Comment by microcap on Apr 13, 2022 11:32pm
They were a few small sales by Wilson and Raghubir around the time of the annual share grant (RSUs). Hardly cause for concern. The three discontinued products totaled less than $2M in revenue in 2021. Of course this headwind will reduce the growth rate in 2022, but important to keep in mind that only one was meaningfully profitable. Yes, Q4 benefited from an inventory build on those, and an ...more  
Comment by Karren411 on May 02, 2022 5:32am